Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Hepatitis B
Interventions
DRUG

Entecavir

0.5 or 1 mg dose qd

Trial Locations (6)

60640

Asian Village Medical Clinic, Chicago

75093

Digestive Health Associates of Texas, Plano

77072

Houston Gastroenterology Clinic, Houston

94304

Stanford University Medical Center, Palo Alto

95116

San Jose Gastroenterology, San Jose

95128

San Jose Gastroenterology, San Jose

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Pacific Health Foundation

OTHER